New consensus guidelines on the pharmacological treatment of schizophrenia

shutterstock_11411980 consensus

The British Association for Psychopharmacology regularly publish consensus guidelines on the pharmacological treatment of mental health conditions. In the last two years these publications have included guidance on insomnia (PDF), dementia (PDF) and bipolar disorder (PDF).

The latest guideline from the BAP is on the pharmacological treatment of schizophrenia and as usual it’s available in full-text via their website.

The recommendations cover the various stages of the illness, including first-episode, relapse prevention and illness that has proved refractory to standard treatment.

The guideline is primarily aimed at psychiatrists, but may also be of interest to general practitioners, other healthcare providers, patients and their families.

The topics covered are:

  • Early intervention: Prodromal/‘at-risk’ mental states
  • First-episode psychosis
  • Acute psychotic episode
  • Maintaining response
  • Adherence to antipsychotic medication
  • Adverse effects of antipsychotics
  • The pharmacological treatment of schizophrenia during pregnancy and breastfeeding
  • Pharmacological management of negative symptoms
  • Pharmacological strategies for cognitive impairment
  • Pharmacological strategies for comorbid substance misuse
  • Pharmacological treatment of incomplete recovery

Barnes TR; Schizophrenia Consensus Group of British Association for Psychopharmacology. Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology (PDF). J Psychopharmacol. 2011 May;25(5):567-620. Epub 2011 Feb 3.

Share on Facebook Tweet this on Twitter Share on LinkedIn Share on Google+
Mark as read
Create a personal elf note about this blog
Andre Tomlin

Andre Tomlin

André Tomlin is an Information Scientist with 20 years experience working in evidence-based healthcare. He's worked in the NHS, for Oxford University and since 2002 as Managing Director of Minervation Ltd, a consultancy company who do clever digital stuff for charities, universities and the public sector. Most recently André has been the driving force behind the Mental Elf and the National Elf Service; an innovative digital platform that helps professionals keep up to date with simple, clear and engaging summaries of evidence-based research. André is a Trustee at the Centre for Mental Health and an Honorary Research Fellow at University College London Division of Psychiatry. He lives in Bristol with his wife, dog and three little elflings.

More posts - Website

Follow me here –